News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Diego Díaz García: Cancer of Unknown Primary (CUP) remains a clinical challenge
Diego A. Díaz García/X
Jun 12, 2025, 23:25

Diego Díaz García: Cancer of Unknown Primary (CUP) remains a clinical challenge

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, posted on X:

“Cancer of Unknown Primary (CUP) remains a clinical challenge.
Diagnosis relies on immunophenotyping + molecular profiling. Site-specific therapy or platinum-based chemo are standard. Prognosis is poor, trial enrollment is key.”

Diego Díaz García

Title: Cancer of Unknown Primary Site

Authors: Kanwal Raghav

Read the Full Article.

Diego Díaz García: Cancer of Unknown Primary (CUP) remains a clinical challenge

cancer Diego Díaz García Kanwal Raghav OncoDaily Oncology
Special Coverage
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer